Molecules/TREMELIMUMAB

TREMELIMUMAB

CHEMBL2108658

Compare

Molecular Identity

TREMELIMUMAB

ChEMBL ID: CHEMBL2108658

AntibodyApprovedFirst approved 2022

Mechanism of action: Cytotoxic T-lymphocyte protein 4 inhibitor

Properties

Molecular Formula

0.00

Molecular Weight

g/mol

Synonyms(11)

CP-675,206CP-675206ImjudoPF-06753388TICILIMUMABTremelimumabTREMELIMUMABTREMELIMUMAB ACTLTREMELIMUMAB-ACTLTREMELIMUMAB ASTRAZENECATREMELIMUMAB (GENETICAL RECOMBINATION)

Data from ChEMBL (EMBL-EBI)

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Drug Network

Trials and conditions connected to TREMELIMUMAB

Loading drug network...